MedTech Financing Surge Highlights Division Between Established And Emerging Firms
This article was originally published in The Gray Sheet
Executive Summary
Medtech firms in the U.S. and Europe raised $27.4 billion over the 12-month period ended June 30, a 26% jump over the prior 12-month period, though debt represented most of it and funding other than debt actually declined.